Acromegaly and Paranasal sinus hypersecretion
Paranasal sinus hypersecretion is found among people with Acromegaly, especially for people who are male, 40-49 old.
The study analyzes which people have Paranasal sinus hypersecretion with Acromegaly. It is created by eHealthMe based on reports of 10 people who have Acromegaly from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
10 people who have Acromegaly and Paranasal Sinus Hypersecretion are studied.
What is Acromegaly?
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues) is found to be associated with 264 drugs and 162 conditions by eHealthMe.
What is Paranasal sinus hypersecretion?
Paranasal sinus hypersecretion is found to be associated with 729 drugs and 394 conditions by eHealthMe.
Number of Paranasal sinus hypersecretion in Acromegaly reports submitted per year:
Gender of people who have Acromegaly and experienced Paranasal Sinus Hypersecretion *:
- female: 50 %
- male: 50 %
Age of people who have Acromegaly and experienced Paranasal Sinus Hypersecretion *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 57.14 %
- 50-59: 0.0 %
- 60+: 42.86 %
Common co-existing conditions for these people *:
- Pituitary Tumor: 3 people, 30.00%
- Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 2 people, 20.00%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 10.00%
Common drugs taken by these people *:
- Somavert: 7 people, 70.00%
- Zyrtec: 2 people, 20.00%
- Topamax: 2 people, 20.00%
- Nexium: 2 people, 20.00%
- Lexapro: 2 people, 20.00%
- Imitrex: 2 people, 20.00%
- Crestor: 2 people, 20.00%
- Sandostatin Lar: 1 person, 10.00%
- Pradaxa: 1 person, 10.00%
Common symptoms for these people *:
- Headache (pain in head): 10 people, 100.00%
- Dizziness: 8 people, 80.00%
- High Blood Pressure: 8 people, 80.00%
- Nausea And Vomiting: 7 people, 70.00%
- Heart Rate Decreased: 5 people, 50.00%
- Back Pain: 5 people, 50.00%
- Suicidal Ideation: 5 people, 50.00%
- Balance Disorder: 5 people, 50.00%
- Heart Rate Increased: 5 people, 50.00%
- Neoplasm Progression (growth of tumour): 5 people, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Paranasal sinus hypersecretion?Check whether Paranasal sinus hypersecretion is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Treatments, associated drugs and conditions:
COVID vaccines that are related to Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion in Moderna COVID Vaccine
- Paranasal sinus hypersecretion in Pfizer BioNTech Covid Vaccine
- Paranasal sinus hypersecretion in Johnson and Johnson Covid Vaccine
Common drugs associated with Paranasal sinus hypersecretion:
All the drugs that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (729 drugs)
Common conditions associated with Paranasal sinus hypersecretion:
All the conditions that are associated with Paranasal sinus hypersecretion:
- Paranasal sinus hypersecretion (394 conditions)
How the study uses the data?
The study is based on Paranasal sinus hypersecretion and Acromegaly, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Unresponsive To Stimuli and drugs of ingredients of sitagliptin phosphate - 3 seconds ago
- Naproxen and Sumatriptan Succinate drug interaction - 3 seconds ago
- Tenofovir Disoproxil Fumarate and Cushingoid - 11 seconds ago
- Tylenol W/ Codeine and Dementia - 13 seconds ago
- Thyroid Diseases and Blood Electrolytes Decreased - 23 seconds ago
- Diabetes and Bladder Cancer - 31 seconds ago
- Persantine and Haemarthrosis - 32 seconds ago
- Celebrex and High Blood Cholesterol - 43 seconds ago
- Amaryl and Multiple System Atrophy - 50 seconds ago
- Amitriptyline Hydrochloride and Migraine With Aura - 53 seconds ago